Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by made2laston Sep 28, 2017 9:38pm

221 Views

Post# 26756735

RE:RE:Brilliant planification

Hi Death_Metal;

Here you go, read the link below.

"Dr. Kaspler presented how the TLD-1433 injected intratumorally in a Balb/C mouse animal model has a greater than 90% cell kill in human GlioBlastoma Multiforme (“GBM”) cancer treated pre-clinically with a low dose of X-ray (1 Gy, 75 keV) and then activated by Near Infrared (“NIR”) laser light (808 nm, 200 J/cm2), four hours after injection."

https://theralase.com/pressrelease/theralase-presents-x-ray-activation-at-international-world-congress/

The best of luck to all longs;

made2last

Bullboard Posts

Unique Battery Metals opportunity in Quebec